| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
3
| Parsey Merdad (Director) has filed a Form 3 on Sagimet Biosciences Inc. |
| 06/12/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,294 shares
@ $78.12, valued at
$101.1k
Exercised 2,779 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Sold 6,126 shares
@ $78.99, valued at
$483.9k
|
|
| 03/13/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 5,328 shares
@ $79.5, valued at
$423.6k
Exercised 3,455 restricted stock units
@ $0
Exercised 7,999 restricted stock units
@ $0
Granted 16,665 restricted stock units
@ $0
Granted 76,000 options to buy
@ $79.5, valued at
$6M
|
|
| 03/02/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Sold 12,984 shares
@ $79.9619, valued at
$1M
|
|
| 02/23/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 376 shares
@ $56.3805, valued at
$21.2k
|
|
| 01/26/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 29,644 shares
@ $0
Granted 43,715 shares
@ $0
Paid exercise price by delivering 17,749 shares
@ $84.02, valued at
$1.5M
|
|
| 01/03/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Sold 553 shares
@ $85.33, valued at
$47.2k
|
|
| 12/13/2022 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 486 shares
@ $87.97, valued at
$42.8k
Exercised 1,039 restricted stock units
@ $0 |
|
| 09/12/2022 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 481 shares
@ $65.28, valued at
$31.4k
Exercised 1,039 restricted stock units
@ $0 |
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2022 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 348 shares
@ $52.1305, valued at
$18.1k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 20,298 shares
@ $0 |
|
| 11/12/2021 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 2,320 shares
@ $67.32, valued at
$156.2k
Exercised 5,100 restricted stock units
@ $0 |
|
| 08/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 364 shares
@ $56.8565, valued at
$20.7k
Paid exercise price by delivering 1,639 shares
@ $63.91, valued at
$104.7k
Exercised 3,455 restricted stock units
@ $0
Granted 16,625 restricted stock units
@ $0
Granted 96,760 options to buy
@ $63.91, valued at
$6.2M
|
|
| 01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 2,416 shares
@ $60.62, valued at
$146.5k
Exercised 5,101 restricted stock units
@ $0 |
|
| 08/19/2020 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 182 shares
@ $57.426, valued at
$10.5k
Sold 182 shares
@ $68.32, valued at
$12.4k
|
|
| 07/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2019 |
3
| Parsey Merdad (Chief Medical Officer) has filed a Form 3 on GILEAD SCIENCES INC |